French (CAC) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED Jul 22, 2024

Explore the French (CAC) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

57 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

SAN

Sanofi
€93.501.2%-4.8%€117.1b€108.56PE25.8xE16.8%4.0%

IPN

Ipsen
€110.501.1%-0.8%€9.1b€127.28PE14.8xE6.7%1.1%

ALVAL

Valbiotis
€1.262.6%-70.6%€19.9m€5.10PS4.2xE43.8%n/a

ABNX

ABIONYX Pharma
€1.251.1%3.3%€43.3m€11.50PS9.3xE-18.7%n/a

ALTHX

Theranexus Société Anonyme
€0.734.0%-42.6%€5.6m€4.00PS19.1xn/an/a

ALBPS

Biophytis
€0.574.9%-92.9%€3.0mn/aPE-0.2xE18.5%n/a

ALTAO

Aton
€0.0122.6%-79.0%€4.9mn/an/an/an/a

ALONC

Oncodesign Société Anonyme
€14.420%57.3%€99.4m€18.64PS3xE101.2%n/a

OSE

OSE Immunotherapeutics
€6.460%89.2%€140.5m€10.15PS63.1xE5.9%n/a

PHXM

PHAXIAM Therapeutics
€1.950%-67.9%€19.5m€5.10PS14.7xE6.2%n/a

ALTME

TME Pharma
€0.150%-89.3%€6.4mn/aPE-1xn/an/a

GNRO

GeNeuro
€0.0870%-94.4%€2.6m€2.05PE-0.2xE-37.3%n/a

VLA

Valneva
€3.460%-48.9%€482.0m€8.63PS3.2xE16.0%n/a

MLCOT

Gour Medical
€0.040%0%€536.3kn/an/an/an/a

ALECR

Eurofins-Cerep
€19,700.000%-32.5%€99.4mn/aPE13xn/an/a

ADOC

Adocia
€6.050%20.8%€91.0m€6.30PS15xE63.0%n/a

ALCOX

Nicox
€0.170%-61.0%€10.9m€1.00PS3.1xE16.1%n/a

ALNOV

Novacyt
€0.560%-30.6%€39.4mn/aPS2.9xn/an/a

ALCLS

Cellectis
€1.880%-15.8%€135.4mn/aPS12.1xE21.0%n/a

SIGHT

GenSight Biologics
€0.310%-57.3%€32.1mn/aPS10.8xE-34.3%n/a

DBV

DBV Technologies
€0.900%-70.2%€86.1m€6.00PS6.3xE21.7%n/a

ALACT

Acticor Biotech SAS
€0.550%-90.0%€8.6m€1.00PE-0.5xE108.4%n/a

PCA

PCAS
€8.000%11.1%€109.9mn/aPE12.5xn/a0%

ALGEN

genOway Société anonyme
€4.060%6.8%€36.6mn/aPE23.3xn/an/a
Page 1 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.